Skin peptides are short amino acid chains used in laboratory research to study how dermal cells communicate, remodel their extracellular matrix and respond to injury signals. The best-known examples include the copper-binding tripeptide GHK-Cu, the palmitoylated pentapeptide Pal-KTTKS and the acetylated hexapeptide Ac-EEMQRR-NH2. Researchers use them in cultured fibroblasts, keratinocytes and three-dimensional skin models to examine collagen synthesis, matrix metalloproteinase activity, gene expression and neuromuscular signalling pathways. This article describes their structure, mechanisms, published in-vitro and animal findings, laboratory applications, and the purity, storage and handling requirements that determine whether results are reproducible.
What are skin peptides?
“Skin peptides” is a research-category term rather than a single compound. It covers synthetic and naturally derived oligopeptides studied for their activity on cells of the dermis and epidermis. Three groups appear most often in the literature: signal peptides, carrier peptides and neurotransmitter-modulating peptides.
Signal peptides mimic fragments released when extracellular matrix proteins are broken down. These fragments, sometimes called matrikines, are thought to act as feedback signals that tell cells to synthesise new matrix. Pal-KTTKS is the standard example. Its core sequence, lysine-threonine-threonine-lysine-serine, corresponds to a fragment of the type I procollagen C-terminal propeptide, and the palmitoyl group attached to the N-terminus increases lipophilicity. The palmitoylated form has a molecular weight of roughly 802 daltons, while the unmodified pentapeptide weighs about 563.
Carrier peptides bind and deliver metal ions, and GHK-Cu is the principal example. GHK is glycyl-L-histidyl-L-lysine, a tripeptide of about 340 daltons that binds copper(II) with high affinity. The copper complex weighs roughly 403 daltons. Loren Pickart and colleagues first isolated it from human plasma albumin in 1973, and plasma concentrations were later reported to be highest in younger individuals, at around 200 ng/mL at age twenty, declining to about 80 ng/mL by age sixty.
The third group modulates neurotransmitter release. Acetyl hexapeptide-8, with the sequence Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2 and a mass near 889 daltons, was designed from the N-terminal region of SNAP-25, a protein in the SNARE complex that controls vesicle fusion. Its acetylated N-terminus and amidated C-terminus protect it from exopeptidases, a common design strategy for skin peptides in general.
The unifying feature across all three groups is small size. A short sequence can, in principle, cross the stratum corneum more readily than a protein, and it can be produced with high fidelity by solid-phase synthesis. Both properties explain why these molecules are popular tools in dermal cell research.
Mechanism of action
Each class of skin peptides acts through a different route, so the mechanism depends on the compound under study.
Signal peptides such as Pal-KTTKS are proposed to act through the matrikine concept. When collagen is cleaved by proteases, the released fragments are recognised by cells as evidence of matrix damage. Fibroblasts then respond by increasing synthesis of collagen and other matrix components. The precise receptors for these fragments are not fully characterised, which is one reason the area remains an active research topic. In cell culture, researchers measure the effect by quantifying collagen or hydroxyproline in the culture medium, or by tracking transcript levels of collagen genes.
GHK-Cu has a more complex profile. The copper(II) ion is central to its activity, since copper is a cofactor for enzymes such as lysyl oxidase, which cross-links collagen and elastin. The peptide is thought to facilitate copper uptake into cells, a mechanism proposed in 1980 on the basis of its binding behaviour. More recent work has used the Broad Institute’s Connectivity Map, a public library of gene-expression responses to small molecules, to show that GHK alters the expression of a large share of the human genome. These findings suggest that the peptide influences several pathways at once, including matrix remodelling, antioxidant defence and protein turnover, rather than acting on a single receptor.
Neurotransmitter-modulating peptides such as acetyl hexapeptide-8 work by a different principle. Because the sequence resembles part of SNAP-25, it is proposed to compete for a position within the SNARE complex and to destabilise its assembly. In vitro, researchers study this by measuring vesicle fusion or neurotransmitter release in neuronal cell models. The mechanism is directly relevant to cell biology, and it is considered a useful experimental probe of SNARE function.
Across all three groups, interpretation depends on sequence integrity. A single deleted residue, racemised amino acid or missing acetyl group can change activity substantially, and a copper-peptide complex that has lost its metal will not behave as the intact complex does. Mechanistic conclusions are therefore only as reliable as the analytical characterisation of the material tested.
What the research shows
The literature on skin peptides is substantial, and four areas are particularly well documented. Readers should consult the primary papers for exact methods and figures.
The first is the 1988 study by Maquart and colleagues, published in FEBS Letters, which examined GHK-Cu in fibroblast cultures. The stimulation of collagen synthesis began between 10⁻¹² and 10⁻¹¹ M, peaked at 10⁻⁹ M and was independent of any change in cell number. The authors also noted that a GHK triplet exists in the α2(I) chain of type I collagen, which led them to propose that the tripeptide might be liberated by proteases at a site of injury. In the paper, copper(II) ions alone did not reproduce the effect, which indicates that the intact complex was responsible. The full record is available on PubMed.
The second is the 2018 review by Pickart and Margolina in the International Journal of Molecular Sciences, which examined GHK-Cu in the light of gene-expression data. Using the Connectivity Map, the authors reported that about 31.2% of human genes changed by 50% or more in response to GHK, with 59% increased and 41% suppressed. The review also summarised cell-culture work in which human adult dermal fibroblasts exposed to 0.01, 1 and 100 nM GHK-Cu showed increased production of elastin and collagen, and altered expression of matrix metalloproteinases and their inhibitor TIMP1. The article is open access through PubMed Central.
The third area, also summarised in that review, concerns rodent wound models. A collagen dressing incorporating GHK accelerated wound closure in both healthy and diabetic rats, and treated animals showed higher glutathione and ascorbic acid levels. These are animal findings and describe tissue responses in a controlled experimental model only. They illustrate why GHK-Cu is often used as a reference compound in wound-model research, and they should not be extrapolated beyond that context.
The fourth area is the body of in-vitro work on Pal-KTTKS and related matrikine peptides, which began in the early 1990s with studies of procollagen-derived fragments in cultured fibroblasts. These experiments reported that the fragment stimulated extracellular matrix production in culture, and they established the signal-peptide concept that later work built upon. Because details vary between laboratories and cell types, this area is best described in general terms here, and researchers should read the original publications and subsequent reviews before designing comparable assays.
Research applications
Skin peptides serve several distinct experimental purposes, and the choice of compound follows the question being asked.
In fibroblast culture, they are used to examine collagen, elastin and glycosaminoglycan synthesis, usually measured by hydroxyproline assay, ELISA or quantitative PCR. In keratinocyte and epidermal models, they are applied to study proliferation, differentiation markers and integrin expression. Reconstructed three-dimensional skin equivalents allow researchers to observe how a peptide behaves across layers of tissue, including how well it permeates a model stratum corneum.
In matrix biology, peptides help dissect the balance between matrix synthesis and degradation. Researchers use them alongside inhibitors and gene-silencing tools to determine whether an effect on collagen output reflects increased synthesis, reduced breakdown or both. In oxidative-stress research, copper-binding peptides are used to examine antioxidant gene expression and metal-dependent redox chemistry in cultured cells.
In neurobiology and cell signalling, SNARE-derived peptides act as probes of vesicle fusion. In analytical and formulation science, they serve as model compounds for studying penetration through artificial membranes and excised tissue, and for developing chromatographic and mass-spectrometric methods. In every one of these settings, the quality of the data reflects the quality of the starting material, which is why purity and handling receive such attention.
Purity, storage and handling
Verification begins with reversed-phase high-performance liquid chromatography (RP-HPLC), usually with detection at 214 or 220 nm. This separates the target sequence from deletion peptides, truncated chains and by-products of incomplete deprotection, and reports purity as the share of total peak area belonging to the target. For cell-based assays, a purity of 98% or higher is commonly specified, although the threshold depends on the sensitivity of the experiment. HPLC alone does not confirm identity, so it should be paired with mass spectrometry to confirm that the observed mass matches the theoretical value. For copper complexes, a metal-content check is also worth requesting, since the copper-to-peptide ratio affects activity.
A batch-specific certificate of analysis matters because synthesis is never perfectly repeatable. Two lots of the same sequence can differ in purity, counter-ion content, water content and net peptide content, and a generic specification sheet cannot capture that variation. A proper certificate lists the lot number, the chromatogram, the mass-spectrometry result and the analysis date, so that any result can be traced to a specific vial. Because degradation accelerates once a peptide is reconstituted, batch-level HPLC verification matters more than many researchers expect, particularly with metal complexes. UK laboratories sourcing skin peptides should expect a batch-specific certificate of analysis and lyophilised storage at -20°C, and the practical points for comparing suppliers are set out in How to buy best peptides.
Lyophilised peptides are most stable when kept dry, sealed and cold. Storage at -20°C is the usual recommendation for the long term, and -80°C is sometimes preferred for sensitive sequences. Vials should be brought to room temperature in a desiccator before opening, because condensation introduces moisture that promotes hydrolysis. Sequences containing methionine, such as acetyl hexapeptide-8, are prone to oxidation and benefit from storage under inert gas, and sequences containing glutamine can undergo deamidation over time.
Reconstituted peptides are considerably less stable than the dry powder. Stock solutions are normally prepared in sterile water or a suitable buffer, divided into single-use aliquots and frozen to avoid repeated freeze-thaw cycles. Copper-binding peptides need extra care, because chelating agents such as EDTA and thiol-containing reagents can strip the metal from the complex and change its behaviour in an assay. Buffer composition and pH should therefore be chosen deliberately, and solution stability should be treated as sequence-specific and validated for the conditions used.
Light sensitivity is a further consideration. Copper complexes are coloured and can be affected by prolonged light exposure, and aromatic residues are susceptible to photo-oxidation. Vials are best stored in the dark or in amber glass, and bench exposure should be kept short. Each aliquot should be labelled with the date, lot number and concentration so that any later anomaly can be traced.
Frequently asked questions
What are skin peptides used for in laboratory research?
They are used to study dermal cell biology, including collagen and elastin synthesis in fibroblast cultures, keratinocyte behaviour, matrix metalloproteinase activity and gene expression. Different compounds suit different questions, so selection depends on the pathway, cell model and assay readout under investigation.
How do I check the purity of a research peptide?
Request the batch-specific certificate of analysis and confirm that it includes an RP-HPLC chromatogram with percentage purity and a mass-spectrometry result matching the theoretical molecular weight. For critical work, independent analysis by your own facility or a third-party laboratory provides further assurance.
How should lyophilised skin peptides be stored?
Keep them sealed, dry and protected from light, typically at -20°C for long-term storage. Allow vials to reach room temperature in a desiccator before opening to prevent condensation, and limit how often the container is opened to reduce moisture uptake and oxidation.
How stable are reconstituted copper peptides?
Stability depends on the sequence, solvent, pH and the presence of chelating agents, and solutions degrade much faster than the powder. Divide stock into single-use aliquots, avoid EDTA and thiol reagents, and validate stability under your own assay conditions rather than relying on a general figure.
The compounds discussed in this article are supplied for in-vitro laboratory research only and are not for human or veterinary use.